The world’s most coveted shipwreck is finally giving up its secrets. After centuries on the Caribbean seabed, the Spanish ...

Financial services leaders are exploring Agentic AI's potential. The BFSI sector is a key testing ground for these advanced ...

Ramelius Resources Limited ( ($AU:RMS) ) has provided an announcement. Ramelius Resources Limited has announced an on-market buy-back of its ...

Shampoo from Cécred, beard oil from Bask & Lather, and a festive bottle of Martell were just a few of the goodies in this ...

By 2026, Asia is expected to hold US$363 trillion in onshore addressable wealth among affluent and high-net-worth individuals. However, while the region’s wealth has surged, the infrastructure ...

In addition to closing schools, Rdale is looking at cutting $5.6 million in programing and transportation.  Directors on the ...

Designed with scalable technology that aligns with investment managers' operating models, RMS Enterprise now helps research organizations optimize their investment process, including internal research ...

Mapi is actively seeking additional partnerships for its new proprietary Depot products. Company management will be available for one-on-one meetings during the Annual Evercore Annual Healthcare ...

What Happened: After conducting a thorough analysis, Echelard sold 5,000 shares of TG Therapeutics. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission ...

TG Therapeutics remains attractive for investors despite competition and slowing growth. Read the latest analysis on the stock here.

Kimberly Lankford is an insurance staff writer at Buy Side. Edited By Written by Staff Deputy Editor, Buy Side Les Masterson is a staff Deputy Insurance Editor at Buy Side and has over 10 years of ...

It might be of some concern to shareholders to see the Ramelius Resources Limited (ASX:RMS) share price down 11% in the last month. But that doesn't change the fact that the returns over the last ...